Enhanced activity of very low density lipoprotein receptor II promotes SGC7901 cell proliferation and migration

Life Sciences

Volumn 84, Issue 13-14, 2009, Pages 402-408

  Yang, Pu ^a   Liu, Zhiguo ^a   Wang, Hongxing ^a   Tian, Jun ^a   Li, Yinghong ^a   Zong, Yiqiang ^a   Qu, Shen ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

catenin; catenin TCF; Migration; Proliferation; Subtypes; VLDLR

Indexed keywords

BETA CATENIN; GELATINASE A; GELATINASE B; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; RECOMBINANT DNA; RETINOIC ACID; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN RECEPTOR; VERY LOW DENSITY LIPOPROTEIN RECEPTOR 1; VERY LOW DENSITY LIPOPROTEIN RECEPTOR II;

ARTICLE; CARCINOMA CELL; CELL ASSAY; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH ADENOCARCINOMA; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

BETA CATENIN; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; LIGANDS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RECEPTORS, LDL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TRETINOIN;

EID: 61849140072     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.12.020     Document Type: Article

References (38)

1. Aberle H., Bauer A., Stappert J., Kispert A., and Kemler R. Beta-catenin is a target for the ubiquitin-proteasome pathway. The EMBO Journal 16 13 (1997) 3797-3804
2. Baker E.A., Stephenson T.J., Reed M.W., and Brown N.J. Expression of proteinases and inhibitors in human breast cancer progression and survival. Molecular Pathology 55 5 (2002) 300-304
3. Chen T., Wu F., Chen F.M., Tian J., and Qu S. Variations of very low-density lipoprotein receptor subtype expression in gastrointestinal adenocarcinoma cells with various differentiations. World Journal of Gastroenterology 11 18 (2005) 2817-2821
4. Chen Y., Hu Y., Lu K., Flannery J.G., and Ma J.X. Very low density lipoprotein receptor, a negative regulator of the Wnt signaling pathway and choroidal neovascularization. The Journal of Biological Chemistry 282 47 (2007) 34420-34428
5. Counter C.M., Meyerson M., Eaton E.N., Ellisen L.W., Caddle S.D., Haber D.A., and Weinberg R.A. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 16 9 (1998) 1217-1222
6. D'Arcangelo G., Homayouni R., Keshvara L., Rice D.S., Sheldon M., and Curran T. Reelin is a ligand for lipoprotein receptors. Neuron 24 2 (1999) 471-479
7. Elkin R.G., and Zhong Y. Assessment of reproductive function in mutant restricted ovulator carrier roosters. Poultry Science 81 9 (2002) 1280-1282
8. Frykman P.K., Brown M.S., Yamamoto T., Goldstein J.L., and Herz J. Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proceedings of the National Academy of Sciences of the United States of America 92 18 (1995) 8453-8457
9. Geng Y., Kodama T., and Hansson G.K. Differential expression of scavenger receptor isoforms during monocyte-macrophage differentiation and foam cell formation. Arteriosclerosis and Thrombosis 14 5 (1994) 798-806
10. Heisberger T., Trommsdorff M., Howell B.W., Goffinet A., Mumby M.C., Cooper J.A., and Herz J. Direct binding of Reelin to VLDL receptor and apoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24 2 (1999) 481-489
11. Hermann M., Mahon M.G., Lindstedt K.A., Nimpf J., and Schneider W.J. Lipoprotein receptors in extraembryonic tissues of the chicken. The Journal of Biological Chemistry 275 22 (2000) 16837-16844
12. Herz J., Kowal R.C., Ho Y.K., Brown M.S., and Goldstein J.L. Low density lipoprotein receptor-related protein mediates endocytosis of monoclonal antibodies in cultured cells and rabbit liver. The Journal of Biological Chemistry 265 34 (1990) 21355-21362
13. Iijima H., Miyazawa M., Sakai J., Magoori K., Ito M.R., Suzuki H., Nose M., Kawarabayasi Y., and Yamamoto T.T. Expression and characterization of a very low density lipoprotein receptor variant lacking the O-link sugar region generated by alternative splicing. Journal of Biochemistry 124 4 (1998) 747-755
14. Kim N.M., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., Coviello G.M., Wright W.E., Weinrich S.L., and Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science 266 5193 (1994) 2011-2015
15. Koch S., Strasser V., Hauser C., Fasching D., Brandes C., Bajari T.M., Schneider W.J., and Nimpf J. A secreted soluble form of apoE receptor 2 acts as a dominant-negative receptor and inhibits Reelin signaling. The EMBO Journal 21 22 (2002) 5996-6004
16. Li X., Guo L., Dressman J.L., Asmis R., and Smart E.J. A novel ligand-independent apoptotic pathway induced by scavenger receptor classB, type I and suppressed by endothelial Nitric-oxide synthase and high density lipoprotein. The Journal of Biological Chemistry 280 19 (2005) 19087-19096
17. Li Y., Lu W., and Bu G. Striking differences of LDL receptor-related protein 1B expression in mouse and human. Biochemical and Biophysical Research Communications 333 3 (2005) 868-873
18. Logan C.Y., and Nusse R. The Wnt signaling pathway in development and disease. Annual Review of Cell and Developmental Biology 20 (2004) 781-810
19. Lynch C.C., and Matrisian L.M. Matrix metalloproteinases in tumor-host cell communication. Differentiation 70 9-10 (2002) 561-573
20. Maeta H., Ohgi S., and Terada T. Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas. Virchows Archiv 438 2 (2001) 121-128
21. Marschang P., Brich J., Weeber E.J., Sweatt J.D., Shelton J.M., Richardson J.A., Hammer R.E., and Herz J. Normal development and fertility of knockout mice lacking the tumor suppressor gene LRP1b suggest functional compensation by LRP1. Molecular and Cellular Biology 24 9 (2004) 3782-3793
22. Multhaupt H.A., Gafvels M.E., Kariko K., Jin H., Arenas-Elliot C., Goldman B.I., Strauss III J.F., Angelin B., Warhol M.J., and McCrae K.R. Expression of very low density lipoprotein receptor in the vascular wall. Analysis of human tissues by in situ hybridization and immunohistochemistry. The American Journal of Pathology 148 6 (1996) 1985-1997
23. Nakamura Y., Yamamoto M., and Kumamaru E. A variant very low density lipoprotein receptor lacking 84 base pairs of o-linked sugar domain in the human brain myelin. Brain Research 793 1-2 (1998) 47-53
24. Nakamura Y., Yamatomo M., and Kumamaru E. Very low-density lipoprotein receptor in fetal intestine and gastric adenocarcinoma cells. Archives of Pathology & Laboratory Medicine 124 1 (2000) 119-122
25. Nakamura Y., Yamamoto M., and Kumamaru E. Significance of the variant and full-length forms of the very low density lipoprotein receptor in brain. Brain Research 922 2 (2001) 209-215
26. Nykjaer A., and Willnow T.E. The low-density lipoprotein receptor gene family: a cellular Swiss army knife?. Trends in Cell Biology 12 6 (2002) 273-280
27. Ohkubo N., Lee Y.D., Morishima A., Terashima T., Kikkawa S., Tohyama M., Sakanaka M., Tanaka J., Maeda N., Vitek M.P., and Mitsuda N. Apolipoprotein E and Reelin ligands modulate tau phosphorylation through an apolipoprotein E receptor/disabled-1/glycogen synthase kinase-3beta cascade. The FASEB Journal 17 2 (2003) 295-307
28. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. Journal of Pathology 200 4 (2003) 448-464
29. Svensson P.A., Englund M.C., Snackestrand M.S., Hagg D.A., Ohlsson B.G., Stemme V., Mattsson-Hulten L., THelle D.S., Fagerberg B., Wiklund O., Carlsson L.M., and Carlsson B. Regulation and splicing of scavenger receptor class B type I in human macrophages and atherosclerotic plaques. BMC Cardiovascular Disorders 5 (2005) 25
30. Takahashi S., Kawarabayasi Y., Nakai T., Sakai J., and Yamamoto T. Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proceedings of the National Academy of Sciences of the United States of America 89 19 (1992) 9252-9256
31. Tian J., Bi H., Li Y.H., Yang P., Zong Y.Q., Wang Y., and Qu S. Function and significance of very low density lipoprotein receptor subtype. Journal of Huazhong University of Science and Technology 25 3 (2005) 229-233
32. Tveten K., Ranheim T., Berge K.E., Leren T.P., and Kulseth M.A. Analysis of alternatively spliced isoforms of human LDL receptor mRNA. Clinica Chimica Acta 373 1-2 (2006) 151-157
33. VanSaun M.N., and Matrisian L.M. Matrix metalloproteinases and cellular motility in development and disease. Birth Defects Research Part C Embryo Today 78 1 (2006) 69-79
34. Wada Y., Homma Y., Nakazato K., Ishibashi T., and Maruyama Y. Effect of overexpression of very low density lipoprotein receptor on cell growth. Heart Vessels 15 2 (2000) 74-80
35. Webb D.J., Nguyen D.H., Sankovic M., and Gonias S.L. The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer motility in vitro. The Journal of Biological Chemistry 274 11 (1999) 7412-7420
36. Wu B., Crampton S.P., and Hughes C.C. Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity 26 2 (2007) 227-239
37. Xu D., Gruber A., Peterson C., and Pisa P. Suppression of telomerase activity in HL-60 cells after treatment with differentiating agent. Leukemia 10 8 (1996) 1354-1357
38. Yang G., Bao L., Zhao J., and Qu S. Investigation of the distribution and changes of VLDLR subtype in fibrotic cardiac muscles. Journal of Tongji Medical University 20 4 (2000) 297-300